NCT01282359

Brief Summary

The asthma clinical practice guidelines categorize with the highest evidence level the effectiveness of educational programs. However, health care professionals not regularly applied it. This may contribute to inadequate control of the disease. Consequently, their designs and implementation strategies should be reviewed. Hypothesis. An asthma educational program based on a limited intervention, managed by professionals with minimal training in education, could provide a significant decrease in the morbidity of the disease. Objective. Determine the effectiveness, in terms of prevention of exacerbations (future risk) and improved asthma control (current control) of an educational program based on a reduced or minimal intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for phase_4 asthma

Timeline
Completed

Started Oct 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 19, 2011

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 25, 2011

Completed
8 months until next milestone

Study Start

First participant enrolled

October 1, 2011

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2013

Completed
Last Updated

September 16, 2015

Status Verified

September 1, 2015

Enrollment Period

1.5 years

First QC Date

January 19, 2011

Last Update Submit

September 15, 2015

Conditions

Keywords

Educational asthma programClusters analysis studyAsthma Control Test

Outcome Measures

Primary Outcomes (1)

  • Number of asthma exacerbations

    Patients will be followed for a year in four programmed visits. At baseline and at follow-up visits, will be collected in each patient the number of asthma exacerbations.

    1 year

Secondary Outcomes (1)

  • ACT score

    1 year

Study Arms (3)

Clinical Practice Group

OTHER

Patients collected in centres randomized as usual clinical practice, who will not receive the limited educational asthma program.

Other: Clinical practice group

"Gold Standard" educational group

OTHER

Patients will receive a formal program of structured and individualized education, enrolled in centres recognized by using high standard procedures in asthma education.

Other: "Gold Standard" educational group

Intervention group

OTHER

This group will receive a limited educational asthma program (minimal educational intervention)

Other: Intervention group

Interventions

Clinical practice group will not receive any specific education

Clinical Practice Group

"Gold Standard" educational group will receive a formal program of structured and individualized education

"Gold Standard" educational group

Intervention group will take the limited educational asthma program which have three parts: basic information, establishment and revision of a small Action Plan (MiniPlan) and training and review of the inhalation skill of the prescribed device. Educators involved will attend a short workshop (6 h), where they will be trained in the program.

Intervention group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female asthma patients with mild or moderate persistent asthma after treatment according to criteria of the GINA2009.
  • Aged 18 and under 70 years.
  • With ACT (Asthma Control Test) \<20 treated at the outpatient clinics of the participating centers.

You may not qualify if:

  • Severe exacerbation of asthma (which required emergency room visit and/or hospitalization) within 30 days prior to visit 1.
  • Severe disabling comorbidity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital de la Santa Creu i Sant Pau

Barcelona, Barcelona, 08025, Spain

Location

Related Publications (3)

  • Morell F, Genover T, Reyes L, Benaque E, Roger A, Ferrer J. [Monitoring of asthma outpatients after adapting treatment to meet international guidelines]. Arch Bronconeumol. 2007 Jan;43(1):29-35. doi: 10.1016/s1579-2129(07)60017-2. Spanish.

    PMID: 17257561BACKGROUND
  • Mansour ME, Rose B, Toole K, Luzader CP, Atherton HD. Pursuing perfection: an asthma quality improvement initiative in school-based health centers with community partners. Public Health Rep. 2008 Nov-Dec;123(6):717-30. doi: 10.1177/003335490812300608.

    PMID: 19711653BACKGROUND
  • Henry RL, Gibson PG, Vimpani GV, Francis JL, Hazell J. Randomized controlled trial of a teacher-led asthma education program. Pediatr Pulmonol. 2004 Dec;38(6):434-42. doi: 10.1002/ppul.20095.

    PMID: 15690558BACKGROUND

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Antolin Lopez, MD

    Hospital Universitario Puerta Hierro Madrid (Spain)

    STUDY CHAIR
  • Meritxell Peiro

    Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    STUDY CHAIR
  • José M Ignacio, MD

    Hospital Serrania de Ronda. Málaga (Spain).

    STUDY CHAIR
  • José A Quintano, MD

    Centro de Salud Lucena I. Lucena. Córdoba (Spain).

    STUDY CHAIR
  • Santiago Bardagí, MD

    Hospital de Mataró. Barcelona (Spain)

    STUDY CHAIR
  • Vicente Plaza, MD

    Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 19, 2011

First Posted

January 25, 2011

Study Start

October 1, 2011

Primary Completion

April 1, 2013

Study Completion

September 1, 2013

Last Updated

September 16, 2015

Record last verified: 2015-09

Locations